SMAD2 and systemic lupus erythematosus: In the NZB/WF1 mouse model of systemic lupus erythematosus (SLE), mice in the low-LF diet group were able to significantly increase antioxidant activity and inhibit hepatic fibrosis by decreasing the expression of fibrotic cytokines and Smad2/3 activation [31].